---

$3.90

+0.0850 ( +2.23% ) 1.7M

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-03-12	Sale	-106837.00	Frank Steven
2024-03-12	Sale	-106837.00	KINDLER JEFFREY B
2023-12-29	Buy	96686.00	KIRK RANDAL J
2023-12-29	Sale	-96686.00	KINDLER JEFFREY B
2023-09-25	Buy	25000.00	MITCHELL DEAN J
2023-08-25	Sale	-141587.00	Sabzevari Helen
2023-08-25	Sale	-21710.00	Lehr Donald P.
2023-08-25	Sale	-18878.00	Perez Jeffrey Thomas
2023-08-25	Sale	-17934.00	Thomasian Harry Jr.
2023-08-25	Sale	-15480.00	Shah Rutul R